Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1992 1
1999 1
2000 2
2002 1
2004 3
2005 4
2006 2
2007 3
2008 5
2009 3
2010 2
2011 4
2012 7
2013 5
2014 9
2015 13
2016 29
2017 25
2018 27
2019 37
2020 39
2021 38
2022 21
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 28082437

229 results
Results by year
Filters applied: . Clear all
Page 1
Whole-Body 18F-FDG PET/CT Is Superior to CT as First-Line Diagnostic Imaging in Patients Referred with Serious Nonspecific Symptoms or Signs of Cancer: A Randomized Prospective Study of 200 Patients.
Lebech AM, Gaardsting A, Loft A, Graff J, Markova E, Bertelsen AK, Madsen JL, Andersen KF, Benzon EV, Helms M, Mathiesen LR, David KP, Kronborg G, Kjaer A. Lebech AM, et al. J Nucl Med. 2017 Jul;58(7):1058-1064. doi: 10.2967/jnumed.116.175380. Epub 2017 Jan 12. J Nucl Med. 2017. PMID: 28082437 Free article. Clinical Trial.
Diagnostic performance of 18F-FDG PET/CT and whole-body diffusion-weighted imaging with background body suppression (DWIBS) in detection of lymph node and bone metastases from pediatric neuroblastoma.
Ishiguchi H, Ito S, Kato K, Sakurai Y, Kawai H, Fujita N, Abe S, Narita A, Nishio N, Muramatsu H, Takahashi Y, Naganawa S. Ishiguchi H, et al. Ann Nucl Med. 2018 Jun;32(5):348-362. doi: 10.1007/s12149-018-1254-z. Epub 2018 Apr 17. Ann Nucl Med. 2018. PMID: 29667143 Free PMC article.
Limited screening with versus without (18)F-fluorodeoxyglucose PET/CT for occult malignancy in unprovoked venous thromboembolism: an open-label randomised controlled trial.
Robin P, Le Roux PY, Planquette B, Accassat S, Roy PM, Couturaud F, Ghazzar N, Prevot-Bitot N, Couturier O, Delluc A, Sanchez O, Tardy B, Le Gal G, Salaun PY; MVTEP study group. Robin P, et al. Lancet Oncol. 2016 Feb;17(2):193-199. doi: 10.1016/S1470-2045(15)00480-5. Epub 2015 Dec 8. Lancet Oncol. 2016. PMID: 26672686 Clinical Trial.
Risk factors and stratification for recurrence of patients with differentiated thyroid cancer, elevated thyroglobulin and negative I-131 whole-body scan, by restaging 18F-FDG PET/CT.
Okuyucu K, Ince S, Alagoz E, Emer O, San H, Balkan E, Ayan A, Meric C, Haymana C, Acıkel C, Gunalp B, Karacalioglu AO, Arslan N. Okuyucu K, et al. Hell J Nucl Med. 2016 Sep-Dec;19(3):208-217. doi: 10.1967/s002449910402. Epub 2016 Nov 8. Hell J Nucl Med. 2016. PMID: 27824959
Comparison of whole body magnetic resonance imaging (WBMRI) to whole body computed tomography (WBCT) or 18F-fluorodeoxyglucose positron emission tomography/CT (18F-FDG PET/CT) in patients with myeloma: Systematic review of diagnostic performance.
Gariani J, Westerland O, Natas S, Verma H, Cook G, Goh V. Gariani J, et al. Crit Rev Oncol Hematol. 2018 Apr;124:66-72. doi: 10.1016/j.critrevonc.2018.02.012. Epub 2018 Mar 2. Crit Rev Oncol Hematol. 2018. PMID: 29548488 Review.
229 results